Tags

Type your tag names separated by a space and hit enter

High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Indian J Med Microbiol. 2009 Jan-Mar; 27(1):48-50.IJ

Abstract

Serum samples from 465 subjects aged between 1 and 25 years were tested for antibody against hepatitis A virus (HAV) [anti-HAV IgG and IgM] to determine the seroprevalence of HAV antibody and do a cost-benefit analysis for decision making about vaccination against HAV among the general population of Bangladesh. A high prevalence of anti-HAV (74.8%) was observed in the study population; the whole study population was found positive for anti-HAV by the age of 25 years. On performing the cost-benefit analysis, it was found that the cost for vaccination with screening for anti-HAV was almost three times cheaper than vaccination without screening. Thus, in the present socioeconomic condition of Bangladesh, a policy based on screening for HAV antibody before vaccination is recommended.

Authors+Show Affiliations

Department of Virology, Bangabandhu Sheikh Mujib Medical University, Shahabag, Dhaka, Bangladesh.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19172060

Citation

Ahmed, M, et al. "High Prevalence of Hepatitis a Virus Antibody Among Bangladeshi Children and Young Adults Warrants Pre-immunization Screening of Antibody in HAV Vaccination Strategy." Indian Journal of Medical Microbiology, vol. 27, no. 1, 2009, pp. 48-50.
Ahmed M, Munshi SU, Nessa A, et al. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Indian J Med Microbiol. 2009;27(1):48-50.
Ahmed, M., Munshi, S. U., Nessa, A., Ullah, M. S., Tabassum, S., & Islam, M. N. (2009). High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Indian Journal of Medical Microbiology, 27(1), 48-50.
Ahmed M, et al. High Prevalence of Hepatitis a Virus Antibody Among Bangladeshi Children and Young Adults Warrants Pre-immunization Screening of Antibody in HAV Vaccination Strategy. Indian J Med Microbiol. 2009 Jan-Mar;27(1):48-50. PubMed PMID: 19172060.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. AU - Ahmed,M, AU - Munshi,S U, AU - Nessa,A, AU - Ullah,M S, AU - Tabassum,S, AU - Islam,M N, PY - 2009/1/28/entrez PY - 2009/1/28/pubmed PY - 2009/3/13/medline SP - 48 EP - 50 JF - Indian journal of medical microbiology JO - Indian J Med Microbiol VL - 27 IS - 1 N2 - Serum samples from 465 subjects aged between 1 and 25 years were tested for antibody against hepatitis A virus (HAV) [anti-HAV IgG and IgM] to determine the seroprevalence of HAV antibody and do a cost-benefit analysis for decision making about vaccination against HAV among the general population of Bangladesh. A high prevalence of anti-HAV (74.8%) was observed in the study population; the whole study population was found positive for anti-HAV by the age of 25 years. On performing the cost-benefit analysis, it was found that the cost for vaccination with screening for anti-HAV was almost three times cheaper than vaccination without screening. Thus, in the present socioeconomic condition of Bangladesh, a policy based on screening for HAV antibody before vaccination is recommended. SN - 1998-3646 UR - https://www.unboundmedicine.com/medline/citation/19172060/High_prevalence_of_hepatitis_A_virus_antibody_among_Bangladeshi_children_and_young_adults_warrants_pre_immunization_screening_of_antibody_in_HAV_vaccination_strategy_ L2 - http://www.ijmm.org/article.asp?issn=0255-0857;year=2009;volume=27;issue=1;spage=48;epage=50;aulast=Ahmed DB - PRIME DP - Unbound Medicine ER -